Positron emission tomography with 18F-fluoro-2-deoxyglucose is an imaging technology that is demonstrating increasing utility in the evaluation of gastrointestinal malignancies.
- positron emission tomography
- PET, positron emission tomography
- FDG, 18F-fluoro-2-deoxyglucose
- CT, computed tomography
- CEA, carcinoembryonic antigen
Statistics from Altmetric.com
Conflicts of interest: RLW has research agreement with GE Medical Systems and Siemens Medical Systems. RLW has received honorariums from GE Medical Systems, Siemens Medical Systems, Phillips, and Mobile Pet Systems. RLW is a stockholder in CTI-MI.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.